Fidelity Select Medical Technology and Devices Portfolio FSMEX

Morningstar Medalist Rating
  • NAV / 1-Day Return$55.69  /  −1.47%
  • Fund Size$3.6B
  • Adjusted Expense Ratio0.620%
  • Net Expense Ratio0.620%
  • Fee Level: DistributionLow
  • Share Class TypeNo Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Mid Blend
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio54%

Morningstar’s Analysis FSMEX

Will FSMEX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Select Medical Tech and Devcs holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FSMEX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings64.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Thermo Fisher Scientific Inc

18.43653M
Healthcare

Danaher Corp

13.62483M
Healthcare

Intuitive Surgical Inc

5.51195M
Healthcare

West Pharmaceutical Services Inc

4.48159M
Healthcare

Waters Corp

4.46158M
Healthcare

10x Genomics Inc Ordinary Shares - Class A

4.26151M
Healthcare

Agilent Technologies Inc

4.23150M
Healthcare

Illumina Inc

3.67130M
Healthcare

Natera Inc

3.32118M
Healthcare

IQVIA Holdings Inc

2.96105M
Healthcare

Sponsor Center